The Veterinary Vaccines market, excluding Foot and Mouth disease, in the US has grown steadily from $2.87 billion in 2013 to $3.40 billion in 2023, indicative of consistent growth. The year-on-year growth rates have slightly declined from a high of 13.53% in 2013 to 1.44% in 2023, with a five-year CAGR of 1.55%, reflecting market maturation.
Future trends to watch include:
- Advancements in biotechnology enhancing vaccine efficacy.
- Increased pet ownership driving demand for preventive veterinary healthcare.
- Growing awareness of zoonotic diseases stimulating vaccine adoption.
- Technological innovation facilitating custom and rapid vaccine development.
